These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6169479)

  • 1. Urinary crystal growth: effect of inhibitor mixtures.
    Werness PG; Bergert JH; Lee KE
    Clin Sci (Lond); 1981 Oct; 61(4):487-91. PubMed ID: 6169479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine.
    Robertson WG; Scurr DS
    J Urol; 1986 Jun; 135(6):1322-6. PubMed ID: 2423714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation.
    Ryall RL; Harnett RM; Marshall VR
    J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gel model for measuring crystallization inhibitor activity].
    Bothor C; Berg W; Börner RH; Jakob M
    Z Urol Nephrol; 1982 Oct; 75(10):689-98. PubMed ID: 6297185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.
    Fellström B; Danielson BG; Ljunghall S; Wikström B
    Clin Chim Acta; 1986 Aug; 158(3):229-35. PubMed ID: 2429785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chondroitin sulphate and heparin on the growth and agglomeration of calcium oxalate monohydrate crystals in vitro.
    Gjaldbaek JC
    Clin Chim Acta; 1982 Apr; 120(3):363-5. PubMed ID: 6804134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium oxalate dihydrate crystal growth.
    Werness PG; Duckworth SC; Smith LH
    Invest Urol; 1979 Nov; 17(3):230-3. PubMed ID: 40922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pH on the urinary inhibition of calcium oxalate crystal growth.
    Tiselius HG
    Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder secretion of inhibitors of calcium oxalate crystal growth.
    Martin X; Opgennorth TJ; Werness PG; Rundquist RT; Romero JC; Smith LH
    Kidney Int; 1985 Oct; 28(4):636-9. PubMed ID: 4087685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct measurement of inhibitory capacity to crystal growth of calcium oxalate in undiluted urine and in other inhibitor containing solutions.
    Baumann JM; Wacker M
    Urol Res; 1980; 8(3):171-5. PubMed ID: 6252673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.
    Zerwekh JE; Hwang TI; Poindexter J; Hill K; Wendell G; Pak CY
    Kidney Int; 1988 May; 33(5):1005-8. PubMed ID: 3134570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.